top of page

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

IDEAYA Biosciences, Inc. - Common Stock (NQ:IDYA)

37.88 -0.08 (-0.21%)

Streaming Delayed Price Updated: 12:06 PM EDT, Jul 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	158,052
Open	37.72
Bid (Size)	37.82 (300)
Ask (Size)	37.94 (200)
Prev. Close	37.96
Today's Range	37.72 - 38.46
52wk Range	21.22 - 40.58
Shares Outstanding	48,390,394
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

IDEAYA Biosciences Spotlights Darovasertib Win, FDA Review Path at Oncology Summit ↗

May 26, 2026

IDEAYA Biosciences (NASDAQ:IDYA) executives highlighted recent clinical progress across the company’s oncology pipeline during a fireside chat at TD Cowen’s seventh annual Oncology Innovation Summit,...

Via MarketBeat

IDEAYA Biosciences Eyes Busy 2026 as Darovasertib Advances Toward FDA Filing ↗

May 25, 2026

IDEAYA Biosciences (NASDAQ:IDYA) Chief Executive Yujiro Hata said the precision oncology company is preparing for a busy 2026, led by regulatory and clinical milestones for darovasertib in metastatic...

Via MarketBeat

Performance

YTD	+11.9%	+11.9%
1 Month	+20.3%	+20.3%
3 Month	+22.4%	+22.4%
6 Month	+0.1%	+0.1%
1 Year	+76.6%	+76.6%

More News

IDEAYA Biosciences Says Melanoma Drug on Track for NDA After Strong Trial Data ↗

May 18, 2026

Via MarketBeat

A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology

May 14, 2026

From USA News Group

Via GlobeNewswire

Why IDEAYA Biosciences Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket ↗

April 13, 2026

Via Benzinga

Get insights into the top gainers and losers of Friday's after-hours session. ↗

April 10, 2026

Via Chartmill

A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you? ↗

March 15, 2026

Via The Motley Fool

A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen) ↗

January 15, 2026

Via Chartmill

IDEAYA Biosciences Inc (NASDAQ:IDYA) Shows Strong Technical Setup for Potential Breakout ↗

December 22, 2025

Via Chartmill

SLB To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

October 21, 2025

Via Benzinga

Buying IDEAYA Might Be The Wrong IDYA Right Now ↗

September 16, 2025

Via Benzinga

Alibaba To Rally Around 35%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

September 09, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 29, 2025

Via Benzinga

IDEAYA (IDYA) Q2 Net Loss Improves 27% ↗

August 05, 2025

Via The Motley Fool

This Royal Caribbean Cruises Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday ↗

July 22, 2025

Via Benzinga

This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗

June 26, 2025

Via Benzinga

This NRG Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

June 26, 2025

Via Benzinga

Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It ↗

November 15, 2024

Via Benzinga

Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise

November 11, 2024

From Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Via Business Wire

This Cognex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

November 05, 2024

Via Benzinga

Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate ↗

September 23, 2024

Via Benzinga

Oracle To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

September 10, 2024

Via Benzinga

IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q2 2024 ↗

August 06, 2024

Via InvestorPlace

Week In Review: ImmuneOnco Out-Licenses Two Antibodies In $2 Billion Deal ↗

August 03, 2024

Via Talk Markets

MarketBeat Week in Review – 7/15 - 7/19

July 20, 2024

Via MarketBeat

Frequently Asked Questions

Is IDEAYA Biosciences, Inc. - Common Stock publicly traded?

Yes, IDEAYA Biosciences, Inc. - Common Stock is publicly traded.

What exchange does IDEAYA Biosciences, Inc. - Common Stock trade on?

IDEAYA Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for IDEAYA Biosciences, Inc. - Common Stock?

The ticker symbol for IDEAYA Biosciences, Inc. - Common Stock is IDYA on the Nasdaq Stock Market

What is the current price of IDEAYA Biosciences, Inc. - Common Stock?

The current price of IDEAYA Biosciences, Inc. - Common Stock is 37.88

When was IDEAYA Biosciences, Inc. - Common Stock last traded?

The last trade of IDEAYA Biosciences, Inc. - Common Stock was at 07/09/26 12:06 PM ET

What is the market capitalization of IDEAYA Biosciences, Inc. - Common Stock?

The market capitalization of IDEAYA Biosciences, Inc. - Common Stock is 1.83B

How many shares of IDEAYA Biosciences, Inc. - Common Stock are outstanding?

IDEAYA Biosciences, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

bottom of page